Daily Endocrinology Research Analysis
Top findings span prevention, safety, and mechanistic discovery in endocrinology: preoperative vitamin D significantly reduces post-thyroidectomy hypocalcemia; routine capillary ketone surveillance in type 1 diabetes on SGLT inhibitors predicts diabetic ketoacidosis risk; and a newborn genome-wide protein QTL map causally implicates multiple proteins in type 1 diabetes, informing early-life targets.
Summary
Top findings span prevention, safety, and mechanistic discovery in endocrinology: preoperative vitamin D significantly reduces post-thyroidectomy hypocalcemia; routine capillary ketone surveillance in type 1 diabetes on SGLT inhibitors predicts diabetic ketoacidosis risk; and a newborn genome-wide protein QTL map causally implicates multiple proteins in type 1 diabetes, informing early-life targets.
Research Themes
- Perioperative endocrine optimization in thyroid surgery
- DKA risk mitigation in T1D using SGLT inhibitors via ketone monitoring
- Genetic-proteomic mechanisms and early-life targets in type 1 diabetes
Selected Articles
1. Genetics of circulating proteins in newborn babies at high risk of type 1 diabetes.
A genome-wide pQTL atlas in 695 genetically at-risk newborns identified 535 protein QTLs, including 62 newborn-specific signals. Colocalization and Mendelian randomization implicated five proteins (CTRB1, APOBR, IL7R, CPA1, PNLIPRP1) as causal in T1D aetiology, highlighting early-life mechanisms and potential targets.
Impact: This is the first comprehensive newborn pQTL map linking circulating proteins to T1D genetics with causal inference, opening avenues for early-life risk stratification and intervention targets.
Clinical Implications: While not immediately practice-changing, these findings prioritize protein targets and biomarkers for early T1D prediction and prevention trials, potentially informing neonatal screening panels in the future.
Key Findings
- Constructed a genome-wide pQTL map for 1,985 proteins in 695 high-risk newborns, identifying 535 pQTLs (352 cis, 183 trans).
- Detected 62 newborn-specific pQTL signals, indicating early-life regulatory architecture.
- Colocalization with T1D GWAS signals and Mendelian randomization causally implicated CTRB1, APOBR, IL7R, CPA1, and PNLIPRP1 in T1D.
Methodological Strengths
- Genome-wide pQTL mapping with both cis and trans resolution in a neonatal cohort.
- Integration of colocalization with GWAS and Mendelian randomization for causal inference.
Limitations
- Cohort limited to newborns at high genetic risk may affect generalizability.
- Cross-sectional neonatal sampling; functional validation of implicated proteins is needed.
Future Directions: Validate protein targets in diverse populations, perform longitudinal tracking from birth to seroconversion/diagnosis, and conduct functional studies to elucidate mechanisms and therapeutic potential.
Type 1 diabetes is a chronic, autoimmune disease characterized by the destruction of insulin-producing β-cells in the pancreas. Early detection can facilitate timely intervention, potentially delaying or preventing disease onset. Circulating proteins reflect dysregulated biological processes and offer insights into early disease mechanisms. Here, we construct a genome-wide pQTL map of 1985 proteins in 695 newborn babies (median age 2 days) at increased genetic risk of developing Type 1 diabetes. We identify 535 pQTLs (352 cis-pQTLs, 183 trans-pQTLs), 62 of which characteristic of newborns. We show colocalization of pQTLs for CTRB1, APOBR, IL7R, CPA1, and PNLIPRP1 with Type 1 diabetes GWAS signals, and Mendelian randomization causally implicates each of these five proteins in the aetiology of Type 1 diabetes. Our study illustrates the utility of newborn molecular profiles for discovering potential drug targets for childhood diseases of significant concern.
2. Preoperative Vitamin D Supplementation to Reduce Hypocalcemia Following Total Thyroidectomy: Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Across 8 RCTs (n=902), preoperative vitamin D reduced overall postoperative hypocalcemia by 23% (RR 0.77) and symptomatic hypocalcemia by 44% (RR 0.56) after total thyroidectomy. Benefits persisted even when restricting to trials without calcium co-supplementation (RR 0.74).
Impact: Meta-analysis of RCTs provides high-level evidence to adopt preoperative vitamin D supplementation as a simple, low-cost strategy to prevent a common endocrine surgical complication.
Clinical Implications: Consider routine vitamin D assessment and short-course supplementation before total thyroidectomy to reduce postoperative hypocalcemia and related symptoms, with protocols adaptable regardless of calcium co-supplementation.
Key Findings
- Across 8 RCTs (902 patients), preoperative vitamin D reduced postoperative hypocalcemia (RR 0.77, 95% CI 0.62–0.96).
- In trials without calcium co-supplementation, vitamin D alone still reduced hypocalcemia (RR 0.74, 95% CI 0.57–0.96).
- Symptomatic hypocalcemia was reduced (RR 0.56, 95% CI 0.34–0.93) across six trials (n=564).
Methodological Strengths
- PRISMA-compliant systematic review and meta-analysis of randomized trials.
- Sensitivity analysis excluding calcium co-supplementation confirmed robustness.
Limitations
- Heterogeneity in dosing regimens and co-interventions across trials.
- Baseline vitamin D status and calcium homeostasis were variably reported.
Future Directions: Define optimal dosing/timing, stratify by baseline vitamin D status, and evaluate cost-effectiveness and protocol integration into perioperative pathways.
OBJECTIVE: This study aims to determine whether preoperative supplementation of vitamin D reduces the incidence of hypocalcemia following total thyroidectomy. METHODS: Conducted in conformity with the PRISMA statement, a systematic review and meta-analysis of randomized clinical trials (RCT) was performed assessing postoperative hypocalcemia and postoperative symptomatic hypocalcemia. RESULTS: The search strategy yielded 3808 potentially relevant publications, with eight RCTs ultimately included. These eight trials included a total of 902 patients (22.73% male, n = 205/902), with a median age of 48.9 years (95% CI, 43.5-53.5). Four trials administered only vitamin D in the interventional arm, three trials administered both calcium and vitamin D in the interventional arm, and one trial administered vitamin D in the interventional arm and calcium in both arms. Pooled results from the eight included trials showed a reduced risk of postoperative hypocalcemia in the intervention arm (RR, 0.77; 95% CI, 0.62-0.96; p = 0.02). When excluding the studies that administered calcium supplements in addition to vitamin D, the pooled results showed a similar reduced risk of postoperative hypocalcemia (RR, 0.74; 95% CI, 0.57-0.96; p = 0.03). Analysis of six trials reporting the incidence of postoperative symptomatic hypocalcemia (n = 564) showed a reduced risk in the vitamin D arm, with or without calcium, compared to the control arm (RR, 0.56; 95% CI, 0.34-0.93; p = 0.023). CONCLUSIONS: Our findings suggest that preoperative vitamin D administration, with or without calcium carbonate, significantly reduces the risk of postoperative hypocalcemia and symptomatic hypocalcemia in patients undergoing total thyroidectomy.
3. Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium-Glucose Cotransporter Inhibitors.
In 1,194 T1D patients assigned to empagliflozin with weekly fasted ketone testing, higher maximum ketone levels in the preceding 28 days predicted DKA/severe ketosis (AUC 0.76). A maximum capillary ketone ≥0.8 mmol/L achieved 66% sensitivity and 79.6% specificity, supporting routine surveillance and informing thresholds for continuous ketone monitoring.
Impact: Provides actionable thresholds for ketone surveillance to mitigate DKA risk in T1D patients using SGLT inhibitors—a critical safety issue hindering broader use.
Clinical Implications: Implement routine capillary ketone monitoring in T1D patients on SGLT inhibitors, flagging maximum values ≥0.8 mmol/L for intensified education, dose review, sick-day rules, or temporary drug interruption.
Key Findings
- Weekly fasted capillary ketones predicted DKA/severe ketosis with an AUC of 0.76 (95% CI 0.71–0.82).
- A maximum ketone threshold of ≥0.8 mmol/L yielded sensitivity 66.0%, specificity 79.6%, and diagnostic odds ratio 7.6.
- Analysis used 28-day rolling windows over 6–12 months in 1,194 empagliflozin-assigned T1D participants, with 49 DKA and 568 severe ketosis events.
Methodological Strengths
- Large sample size with adjudicated outcomes and repeated biomarker measurements.
- Pre-specified rolling-window analysis and ROC-based performance evaluation.
Limitations
- Secondary analysis limited to empagliflozin-assigned participants; generalizability to other SGLT inhibitors uncertain.
- Weekly fasted measurements may miss dynamic changes; sensitivity not sufficient for rule-out.
Future Directions: Prospective validation of thresholds, integration with continuous ketone monitoring, and evaluation of clinical workflows that couple alerts to mitigation protocols.
OBJECTIVE: We aimed to determine if routine capillary blood ketone testing on well days predicts future diabetic ketoacidosis (DKA) in type 1 diabetes (T1D) using sodium-glucose cotransporter inhibitors (SGLTi). RESEARCH DESIGN AND METHODS: We examined previously collected data from empagliflozin-assigned participants in a T1D trial that included weekly fasted ketone levels. Over 6-12 months, ketone levels were subdivided into 28-day periods, and the outcome was subsequent adjudicated DKA or severe ketosis. RESULTS: Among 1,194 participants, 325 had 49 DKA and 568 severe ketosis events. On-treatment maximum ketone levels were higher in the 28 days before an outcome compared with levels in those without an outcome, with area under receiver operating characteristic curve of 0.76 (95% CI 0.71-0.82). Maximum ketone level ≥0.8 mmol/L had sensitivity of 66.0%, specificity of 79.6%, and diagnostic odds ratio of 7.6. CONCLUSIONS: Routine surveillance of capillary ketone levels in T1D using SGLTi may represent a DKA mitigation strategy and implies a potential threshold for continuous ketone monitoring.